MABELIO
DEAD
Serial Number
98112480
Owner
Basilea Pharmaceutica AGAttorney
Evan A. RaynesFiling Date
Aug 1, 2023
MABELIO Trademark
Serial Number: 98112480
MABELIO is a trademark filed by
Basilea Pharmaceutica AG
on August 1, 2023. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently no longer active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Evan A. Raynes SYMBUS LAW GROUP PLLC
1775 I STREET, NW, SUITE 1150
WASHINGTON, DC 20006
United States
Trademark Details
Filing Date
August 1, 2023
Registration Date
Not Registered
Published for Opposition
November 19, 2024
Goods & Services
Pharmaceutical preparations and substances containing small molecule active pharmaceutical ingredients for the treatment of bacterial infections
Filing History
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 2, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 2, 2026 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 18, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jun 17, 2025 EX1G
SOU EXTENSION 1 FILED
Jun 17, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 17, 2025 EEXT
ASSIGNED TO EXAMINER
Apr 25, 2025 DOCK
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 31, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 19, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 19, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 13, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 8, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 2, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 2, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 2, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 1, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 1, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 2, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 2, 2024 GNRT
NON-FINAL ACTION WRITTEN
Apr 2, 2024 CNRT
ASSIGNED TO EXAMINER
Apr 1, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 30, 2023 NWOS
NEW APPLICATION ENTERED
Aug 4, 2023 NWAP
